In vitro susceptibilities and β-lactamase production of 53 clinical isolates of Branhamella catarrhalis

S. Alvarez, M. Jones, S. Holtsclaw-Berk, J. Guarderas

Research output: Contribution to journalArticlepeer-review

49 Scopus citations

Abstract

We tested 53 clinical isolates of Branhamella catarrhalis recovered from patients with respiratory symptoms to determine the susceptibility of the isolates to 25 antimicrobial agents, including the newer β-lactam antibiotics. Of the 53 strains, 46 (86.7%) were β-lactamase producers. All the strains were susceptible to the majority of the new penicillins and cephalosporins. The combinations of amoxacillin-clavulanic acid and ticarcillin-clavulanic acid were also very active against the β-lactamase-producing strains.

Original languageEnglish (US)
Pages (from-to)646-647
Number of pages2
JournalAntimicrobial Agents and Chemotherapy
Volume27
Issue number4
DOIs
StatePublished - 1985

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'In vitro susceptibilities and β-lactamase production of 53 clinical isolates of Branhamella catarrhalis'. Together they form a unique fingerprint.

Cite this